Metformin improves insulin sensitivity, lowers blood glucose and cholesterol, and reduces body weight in some individuals with type 2 diabetes, although the underlying mechanisms of action, which include modulating AMPK activation, remain poorly understood (Viollet et al., 2012). This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.